Flagellin Polypeptide-Based Water Quality Monitoring and Remediation Systems
Legal Citation
Summary of the Inventive Concept
A novel application of Enterococcus gallinarum flagellin polypeptides in water quality monitoring and remediation systems, enabling real-time detection and mitigation of waterborne pathogens and algae growth.
Background and Problem Solved
The original patent disclosed the use of Enterococcus gallinarum flagellin polypeptides in pharmaceutical compositions for treating diseases. However, the patent did not consider the potential of these polypeptides in addressing water quality issues. The new inventive concept solves the problem of inadequate water quality monitoring and remediation by leveraging the flagellin polypeptides' ability to interact with waterborne pathogens and algae.
Detailed Description of the Inventive Concept
The new inventive concept encompasses systems, methods, and devices that utilize isolated Enterococcus gallinarum flagellin polypeptides to monitor and mitigate water pollution. These systems comprise sensors for detecting interactions between the flagellin polypeptides and waterborne pathogens or algae, triggering alarms or remediation responses. The methods involve administering the flagellin polypeptides to water samples, detecting interactions, and tracing the source of waterborne outbreaks. Devices can be designed to remove waterborne pathogens from water supplies or control algae growth in aquatic ecosystems.
Novelty and Inventive Step
The new claims introduce a previously unknown application of Enterococcus gallinarum flagellin polypeptides in water quality monitoring and remediation, which is not obvious from the original patent's disclosure of pharmaceutical compositions. The inventive step lies in recognizing the potential of these polypeptides in interacting with waterborne pathogens and algae, and designing systems, methods, and devices that harness this property for water quality management.
Alternative Embodiments and Variations
Alternative embodiments could include using different bacterial strains or polypeptide sequences, integrating the flagellin polypeptides with existing water treatment infrastructure, or developing portable or point-of-use devices for water quality monitoring and remediation.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the water quality monitoring and remediation market, which is projected to grow substantially in the coming years. Target industries include municipal water treatment, industrial process water management, and environmental monitoring and remediation services.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K39/09 |
| A | A61 | A61K35/744 |
| A | A61 | A61K2039/585 |
| A | A61 | A61P37/04 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Biotechnology and immunology, specifically bacterial polypeptide applications in medical and environmental diagnostics, with expertise in protein interaction, sensor technologies, and microbial pathogen detection
Person of Ordinary Skill (PHOSITA) Profile
A researcher with advanced degrees in microbiology or bioengineering, familiar with protein engineering, sensor design, and interdisciplinary applications of bacterial proteins in diagnostic and remediation technologies
Obviousness Rationale
A PHOSITA would recognize that flagellin polypeptides inherently possess interaction capabilities with biological systems, making their extension from pharmaceutical immune stimulation to water quality monitoring a predictable and logical technical progression. The source patent's detailed characterization of Enterococcus gallinarum flagellin polypeptides provides sufficient structural and functional information to enable alternative applications. The molecular properties that make these polypeptides effective in immune response would naturally suggest potential interactions with pathogens and environmental microorganisms.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,614 |
|---|---|
| Title | Enterococcus gallinarum flagellin polypeptides |
| Assignee(s) | CJ BIOSCIENCE, INC. |